Real‐world efficacy and safety of ritlecitinib in alopecia areata: A single‐centre experience
Journal of the European Academy of Dermatology and Venereology · 2025-12 · 39 (12)
DOI: 10.1111/jdv.20664 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 25.03.2025. Verfasst von Youyu Sheng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Huashan Hospital, Shanghai Institute of Dermatology, State Key Laboratory of Molecular Engineering of Polymers, Fudan Univ…. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 4 Literaturangaben. Gefördert von: Shanghai Engineering Research Center of Hair Medicine, Shanghai Municipal Key Clinical Specialty, Clinical Research Plan of SHDC.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Dermatology, Huashan Hospital, Shanghai Institute of Dermatology, State Key Laboratory of Molecular Engineering of Polymers, Fudan University, Shanghai, China.
- Department of Dermatology, Jing'an District Central Hospital, Shanghai, China.
- Academy for Engineering and Technology, Fudan University, Shanghai, China.
ORCID-Profile: Jinran Lin, Wenyu Wu
Förderung
- Shanghai Engineering Research Center of Hair Medicine
- Shanghai Municipal Key Clinical Specialty
- Clinical Research Plan of SHDC
- National Key Clinical Specialty, National Key Research and Development Program of China
- Key Specialty Research Centre of Shanghai Health Commission
Zitieren
APA
Sheng, Y., Wang, Q., Tao, K., Yang, K., Zhu, Y., Li, Z., Ni, C., Lin, J., & Wu, W. (2025). Real‐world efficacy and safety of ritlecitinib in alopecia areata: A single‐centre experience. Journal of the European Academy of Dermatology and Venereology, 39(12). https://doi.org/10.1111/jdv.20664
Vancouver
Sheng Y, Wang Q, Tao K, Yang K, Zhu Y, Li Z, et al. Real‐world efficacy and safety of ritlecitinib in alopecia areata: A single‐centre experience. Journal of the European Academy of Dermatology and Venereology. 2025;39(12). doi:10.1111/jdv.20664
BibTeX
@article{Sheng2025,
author = {Sheng, Youyu and Wang, Qin and Tao, Ke and Yang, Kai and Zhu, Yifei and Li, Zheng and Ni, Chunya and Lin, Jinran and Wu, Wenyu},
title = {Real‐world efficacy and safety of ritlecitinib in alopecia areata: A single‐centre experience},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2025},
volume = {39},
number = {12},
doi = {10.1111/jdv.20664}
}
EUVIMED